Emerging Thrombotic Disorders Associated with Virus-Based Innovative Therapies: From VITT to AAV Gene Therapy-Related Thrombotic Microangiopathy.

Autor: Benemei S; Medical Affairs, Pfizer Italia, Rome, Italy., Gatto F; Medical Affairs, Pfizer Italia, Rome, Italy., Marcucci R; Department of Experimental and Clinical Medicine, University of Florence and Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy., Gresele P; Section of Internal and Cardiovascular Medicine, Department of Medicine, University of Perugia, Perugia, Italy.

Publikováno v: Thrombosis and haemostasis [Thromb Haemost] 2024 Oct 03. Date of Electronic Publication: 2024 Oct 03.

Mental Pain Questionnaire: An item response theory analysis

Autor: Svicher, A., Romanazzo, S., De Cesaris, F., Benemei, S., Geppetti, P., Cosci, F.

Publikováno v: In Journal of Affective Disorders 15 April 2019 249:226-233

Outcome measures in hemophilia: current and future perspectives.

Autor: Benemei S; Medical Affairs, Pfizer Italia, Rome, Italy., Boni L; U.O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Castaman G; Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy.

Publikováno v: Expert review of hematology [Expert Rev Hematol] 2024 Jul; Vol. 17 (7), pp. 329-340. Date of Electronic Publication: 2024 Jun 19.

The good, the bad and the ugly of pain in haemophilia: Recent evidence on the epidemiology, molecular mechanisms and knowledge gaps preventing optimal treatment.

Autor: Benemei S; Medical Affairs, Pfizer Italia, Rome, Italy., Mattia C; Department of Medical and Surgical Sciences and Biotechnologies, Unit of Anaesthesiology, Intensive Care Medicine and Pain Therapy, Faculty of Pharmacy and Medicine, 'ICOT-Polo Pontino, Sapienza' University of Rome, Rome, Italy., Di Minno MND; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.

Publikováno v: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2024 May; Vol. 30 (3), pp. 589-597. Date of Electronic Publication: 2024 Mar 28.

Switching OnabotulinumtoxinA to Monoclonal Anti-CGRP Antibodies in Drug-Resistant Chronic Migraine.

Autor: Iannone LF; Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Viale Pieraccini 6, Florence, Italy.; Headache Center and Clinical Pharmacology Unit, Careggi University Hospital, Florence, Italy., Fattori D; Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Viale Pieraccini 6, Florence, Italy., Marangoni M; Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Viale Pieraccini 6, Florence, Italy., Benemei S; Headache Center and Clinical Pharmacology Unit, Careggi University Hospital, Florence, Italy., Chiarugi A; Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Viale Pieraccini 6, Florence, Italy.; Headache Center and Clinical Pharmacology Unit, Careggi University Hospital, Florence, Italy., Geppetti P; Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Viale Pieraccini 6, Florence, Italy. pierangelo.geppetti@unifi.it.; Headache Center and Clinical Pharmacology Unit, Careggi University Hospital, Florence, Italy. pierangelo.geppetti@unifi.it., De Cesaris F; Headache Center and Clinical Pharmacology Unit, Careggi University Hospital, Florence, Italy.

Publikováno v: CNS drugs [CNS Drugs] 2023 Feb; Vol. 37 (2), pp. 189-202. Date of Electronic Publication: 2023 Jan 19.